Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
0Activity
0 of .
Results for:
No results containing your search query
P. 1
Proteomics: Technologies and Global Markets

Proteomics: Technologies and Global Markets

Ratings: (0)|Views: 4 |Likes:
Published by BCC Research
The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in 2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during the next five years to reach nearly $8.9 billion in 2017.
The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in 2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during the next five years to reach nearly $8.9 billion in 2017.

More info:

Categories:Types, Brochures
Published by: BCC Research on Jul 11, 2014
Copyright:Traditional Copyright: All rights reserved

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

07/11/2014

pdf

text

original

 
 
T: 866-285-7215, 1-781-489-7301 • F: 781-489-7308sales@bccresearch.com • www.bccresearch.com
 
Proteomics: Technologies andGlobal Markets
May 2013 • BIO034C
Use this report to:
Receive analysis for the main proteomic platforms: mass spectrometry and biochips, as
well as to receive detailed information concerning the individual market segments andindustry dynamics.Focus on the market for proteomic-based diagnostics products, which highlight a major
future market segment for proteomic technologies.Learn about the factors that influence each market, including growth-driving forces,
industry alliances and acquisitions, applications in diagnostics and drug discovery,customer needs and competitive trends.Examine the main patent trends within the industry.
 
To place an order forProteomics: Technologiesand Global Marketscall 866-285-7215May 2013Report ID: BIO034C
Highlights
 The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during thenext five years to reach nearly $8.9 billion in 2017.
This report provides:
An overview of the global proteomics market, which covers: technologies, database and
software markets, equipment markets, application markets and service markets.Analyses of global market trends, with data from 2011 and 2012, and projections of 
compound annual growth rates (CAGRs) through 2017.Discussion of trends and opportunities, top-selling products, key players, and a competitive
outlook.Comprehensive company profiles across subsegments, such as protein chip providers,
reagent providers, service providers, informatics and database providers, etc.SAMPLE FIGUREGLOBAL PROTEOMIC MARKET BY END-USE INDUSTRY, THROUGH 2017($ MILLIONS) To submit your query click here Source: BCC Research
 
Introduction & Scope
INTRODUCTIONSTUDY GOALS AND OBJECTIVES
BCC Research’s goal for this study was to determine the status of proteomictechnologies and products and assess their global growth potential over the five-yearperiod from 2012 to 2017. The market was analyzed for the main proteomic platforms:mass spectrometry and biochips.  The biochip market was characterized by key biochip type (i.e., lab-on-a-chip, planararray, bead array) and by end-use industry (e.g., research, drug discovery anddevelopment, diagnostics, applied). The mass spectrometry (MS) market was characterized by MS instrument type andend-use industry, as well as by MS workflow (e.g., sample preparation, chromatography,tagging and labeling reagents, and informatics).A particular focus of the study is placed on the market for proteomic-based diagnosticsproducts, which highlights a major future market segment for proteomic technologies.
 
To place an order forProteomics: Technologiesand Global Marketscall 866-285-7215May 2013Report ID: BIO034C
 The key objective was to present a comprehensive discussion of the main commercialproteomic technologies, along with the current and future commercial potential foreach of the key market segments.
REASONS FOR DOING THE STUDY 
BCC Research has previously examined the proteomic industry as part of several largerstudies. For example, BCC published a report on biochips in 2011 that covered proteinarrays and lab-on-a-chip (LOAC) products and markets. In 2010, BCC published areport on next-generation cancer diagnostics that covered diagnostics applications forproteomic biochips.  The main objective for the present report is to present the up-to-date market picturefor proteomics into a single comprehensive report. The objective was to capture thechanging industry dynamics and market shift occurring in this industry. Thus, it istimely to examine the key aspects of the proteomic industry. There is also an urgent need in the life science industry for technologies and productsthat can analyze and study the human proteome in a high-throughput, multiplex andlow-cost way. Proteomic technologies are evolving to meet more of these needs, so itis important to keep abreast of these dynamics. This report is intended to inform companies in the life science industries regarding theimportant trends in MS, LOAC and arrays, as well as to provide detailed informationconcerning the individual market segments and industry dynamics.
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
BCC has compiled a study of critical proteomic technologies that are used in the fourmajor end-user segments: research, drug discovery and development, diagnostics andapplied markets. The report discusses the proteomic platforms, market growth drivingforces, product types, key market applications, companies and alliances, industrydynamics, patents, future market potential and product sales forecasts for the periodfrom 2012 through 2017. This study will be of particular interest to the companies in such industries asdiagnostics, pharmaceuticals, biotechnology, nanotechnology, life sciences tools,biodefense, medical devices, analytical instruments, chromatography, chemicals,polymers, glass and bioinformatics. It will also be of interest to companies involved indrug, diagnostic and/or biomarker discovery programs; manufacturers of microarraysand lab-on-a-chip devices; sample prep suppliers; bioinformatics developers; andcancer researchers and clinicians.
SCOPE AND FORMAT
 The study scope covers MS instruments, consumables, workflow products, planararrays, bead arrays and LOAC. It also covers the research, drug discovery anddevelopment, diagnostics and applied end-user market segments. The maingeographical markets—North America, Europe, Japan and Rest of World (ROW)—areincluded.  The MS market is covered by instrument type, MS consumables, product type andend-user markets. The biochip market is covered by biochip type and the-end usermarket for each type. The diagnostics market is covered in some detail, including bymajor platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as theirforecasted growth through 2017. Technology status and market driving forces are discussed. Factors that influenceeach market are also discussed, including growth-driving forces, industry alliances andacquisitions, applications in diagnostics and drug discovery, customer needs andcompetitive trends.

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->